|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online 30 September 2008
doi: 10.1242/jcs.029215
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research Article |
results in impaired cutaneous wound closure and myofibroblast function
1 CIHR Group in Skeletal Development and Remodeling, Division of Oral Biology and Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, University of Western Ontario, London ON, Canada N6A 5C1
2 Centre for Rheumatology, Department of Medicine, Royal Free and University College Medical School, University College London (Royal Free Campus), Rowland Hill Street, London NW3 2PF, UK
3 Centre for Tissue Engineering Research, Department of Biomedical Sciences, University of Westminster, London W1W 6UW, UK
Author for correspondence (e-mail: andrew.leask{at}schulich.uwo.ca)
Accepted 20 July 2008
| Summary |
|---|
|
|
|---|
-smooth muscle actin (
-SMA)-expressing myofibroblast, which migrates into the wound where it adheres to and contracts extracellular matrix (ECM), resulting in wound closure. Persistence of the myofibroblast results in scarring and fibrotic disease. In this report, we show that, compared with wild-type littermates, PKC
-/- mice display delayed impaired cutaneous wound closure and a reduction in myofibroblasts. Moreover, both in the presence and absence of TGFβ, dermal fibroblasts from PKC
-/- mice cultured on fibronectin show impaired abilities to form `supermature' focal adhesions and
-SMA stress fibers, and reduced pro-fibrotic gene expression. Smad3 phosphorylation in response to TGFβ1 was impaired in PKC
-/- fibroblasts. PKC
-/- fibroblasts show reduced FAK and Rac activation, and adhesive, contractile and migratory abilities. Overexpressing constitutively active Rac1 rescues the defective FAK phosphorylation, cell migration, adhesion and stress fiber formation of these PKC
-/- fibroblasts, indicating that Rac1 operates downstream of PKC
, yet upstream of FAK. These results suggest that loss of PKC
severely impairs myofibroblast formation and function, and that targeting PKC
may be beneficial in selectively modulating wound healing and fibrotic responses in vivo.
Key words: Myofibroblasts, TGFβ, Wound healing
| Introduction |
|---|
|
|
|---|
-cytoplasmic actins,
-SMA,
v integrin, vinculin, paxillin,
-actinin, talin, focal adhesion kinase (FAK) and tyrosine-phosphorylated proteins (Dugina et al., 2001
Focal adhesion proteins serve as a point of convergence for signals that result from stimulation of growth factor receptors (Turner, 2000
). For example, paxillin provides a platform for protein tyrosine kinases such as FAK and SRC, which are activated as a result of adhesion or growth factor stimulation (Hagel et al., 2002
). Fibroblasts lacking FAK or paxillin spread poorly and cannot migrate (Ilic et al., 1995
; Webb et al., 2004
). FAK-deficient fibroblasts actually possess more focal adhesions than do control cells, suggesting that FAK recruitment may be involved with the turnover of existing focal adhesions (Ilic et al., 1995
). Indeed, FAK, paxillin, Src and ERK are required for focal adhesion disassembly at the base of extruding lamellopodia (Webb et al., 2004
). FAK recruitment to paxillin is also required for Rac activation (Ishibe et al., 2004
), which is essential for cell migration (Klemke et al., 1998
). FAK activation is also required for matrix contraction (Midwood and Schwarzbauer, 2002
).
Many details still remain to be discovered about the regulation and spatiotemporal relationship of the activation of focal adhesion components. For example, formation of focal adhesions is associated with the stimulation of protein kinase C (PKC) (Woods and Couchman, 1992
), yet the contribution of PKC to focal adhesion formation is not yet understood.
PKC is a family of serine/threonine kinases that regulate a variety of cell functions including proliferation, gene expression, cell cycle, differentiation, cytoskeletal organization cell migration and apoptosis (Carter and Kane, 2004
). The existence of multiple isozymes of PKC has raised the issue of whether each PKC isozyme has a specific function. Indeed, differences in PKC isozyme protein structure and substrate preferences have allowed the family to be divided into three groups (Way et al., 2000
). The conventional PKC isozymes (
, βI, βII, and
) are Ca2+-dependent and are activated by phospholipids and diacylglycerol. The novel isozymes (
,
, µ, and
) are calcium insensitive, but phospholipid and diacylglycerol dependent. Finally, the atypical PKC isozymes (
and
/
) are insensitive to both Ca2+ and diacylglycerol. Although the activation mechanism of the PKC isozyme family is clearly different among the three subgroups: conventional, novel and atypical PKC, whether or not each isozyme in a subgroup has a specific function or activation mechanism has not been clarified. Indeed, many PKCs display overlapping substrate specificities in vitro (Teicher, 2006
). Overall, studies in which active or dominant-negative PKC isoforms are overexpressed in vitro have been imperfect in predicting the physiological consequences of loss of individual PKC isoforms in vivo (Teicher, 2006
). There may be functional compensation by other PKC isoforms in vivo (Teicher, 2006
). Moreover, data from dominant-negative or constitutively active studies can be misleading, as it is not known whether the overexpressed protein only impacts the isoform of interest or also affects other closely related PKC isoforms (Moscat et al., 2006
). Furthermore, as PKC isozymes do not function in isolation but exist in complexes with other signaling molecules, overexpressed proteins may also impact the function of these additional molecules and hence indirectly affect cell function (Teicher, 2006
). Thus, to identify the in vivo functions of individual PKC isoforms, the use of genetic models, such as knockout mice, is essential.
|
(PKC
) contains an actin-binding motif that is unique to this individual member of the PKC gene family (Prekeris et al., 1998
with
-SMA (Bogatkevich et al., 2003
is required for the recycling of integrin β1, to which PKC
is bound via RACK (Besson et al., 2002
is required for the ability of TNF
to cause phosphorylation of STAT1, a process mediated by integrins (Ivaska et al., 2003
may play a crucial role in stress fiber formation at focal adhesions. However, this hypothesis has yet to be tested. Indeed, the precise contribution of PKC
to focal adhesion formation in fibroblasts and in wound closure is not known. PKC
knockout mice are viable and appear essentially normal, but show elevated susceptibility to bacterial infection (Castrillo et al., 2001
knockout mice to assess the contribution of protein kinase C
to focal adhesion formation, adhesion, migration and ECM contraction and wound closure. | Results |
|---|
|
|
|---|
knockout mice show reduced wound closure and presence of
-SMA expressing myofibroblasts
-/- mice displayed a delay in cutaneous wound closure, we subjected 8-week-old mice homozygous for deletions in the PKC
gene, or their wild-type littermates, to the dermal punch wound model of wound healing. We monitored wound closure over a 14-day period, and found that PKC
-/- animals displayed a marked reduction in the rate of wound closure (Fig. 1A). We examined sections taken from isolated tissue from animals 14 days-post wounding and found that PKC
-/- animals showed reduced presence of
-SMA-expressing myofibroblasts therein (Fig. 1B). Decreased
-SMA expression was verified using Western blot analysis if tissue extracts of wounds from PKC
+/+ and PKC
-/- animals (Fig. 1C). These results indicate that the wound healing phenotype of PKC
-/- animals may arise due to impaired myofibroblast activity and function.
PKC
is required for `supermature' focal adhesion formation
To begin to investigate the molecular defects underlying the inability of PKC
-/- to rapidly close dermal wounds, fibroblasts were cultured from the dermis of mice homozygous for deletions in the PKC
gene and wild-type littermates. Genotypes of the fibroblasts were confirmed by western blot analysis and RT-PCR (not shown). Our in vivo data indicated that loss of PKC
led to reduced tissue remodeling, wound closure and myofibroblast activity. To investigate this issue, we investigated whether loss of PKC
affected the ability of fibronectin to induce the appearance of
-SMA stress fibers and intensely vinculin-positive `supermature' focal adhesions, key features of myofibroblasts (Hinz and Gabbiani, 2003
). Fibronectin was used in our assays as this protein is a key component of the provisional matrix laid down in the initial phases of wound healing (Grinnell, 1984
) and therefore provided an appropriate parallel approach to our in vivo wound healing studies. Intriguingly, we found that PKC
-/- fibroblasts cultured on fibronectin were able to recruit actin to form stress, as visualized by staining cells with phalloidin (Fig. 2). However, we found that
-SMA stress fiber networks, as visualized by staining of cells with an anti-
-SMA antibody, did not form in PKC
-/- fibroblasts (Fig. 2). To investigate whether PKC
was required for optimal focal adhesion formation by fibroblasts, we subjected PKC
+/+ and PKC
-/- fibroblasts growing on fibronectin to indirect immunofluorescence with anti-focal adhesion kinase (FAK) and anti-vinculin antibodies. We found that vinculin and phospho-FAK staining were markedly reduced in intensity and number in PKC
-/- fibroblasts (Fig. 2). That intense vinculin staining did not appear in PKC
-/- fibroblasts is consistent with a failure of PKC
-/- cells to support formation of
-SMA stress fibers, as highly vinculin-positive focal adhesions are correlated with the larger, so-called `supermature'
-SMA stress fiber-nucleating FAs (Dugina et al., 2001
).
|
To confirm the notion that PKC
was required for focal adhesion and
-SMA stress fiber formation, cytoskeletal protein preparations were prepared from wild-type and PKC
knockout fibroblasts grown on fibronectin. The resultant protein preparations were subjected to western blot analysis with anti-
-SMA, anti-actin, anti-paxillin, anti-FAK, anti-Rac and anti-vinculin antibodies. Although these components of stress fiber and focal adhesion complexes were readily detected in the insoluble fraction of normal fibroblasts, suggesting that
-SMA stress fibers and focal adhesions were able to be formed in wild-type fibroblasts,
-SMA, paxillin, moesin and vinculin were found at reduced levels the insoluble fraction of PKC
knockout fibroblasts, giving further support to the notion that loss of PKC
impaired the formation of
-SMA stress fibers and focal adhesions (Fig. 3A). Consistent with the notion that an actin network formed in PKC
-/- fibroblasts, actin was recruited to the insoluble fraction of both PKC
+/+ and PKC
-/- fibroblasts (Fig. 3A). Interestingly, however, FAK was found in the insoluble protein fraction, although it displayed reduced phosphorylation (Fig. 3A). These results suggest that the defect in FAK activation lies not at the level of FAK recruitment, but rather at the level of FAK activation. Consistent with this notion, immunoprecipitation experiments with an anti-paxillin antibody, which binds activated FAK and is required for focal adhesion assembly (Turner, 2000
), showed that PKC
-/- fibroblasts showed markedly reduced binding between paxillin and FAK (Fig. 3B). Intriguingly, Rac, a protein activated and localized to focal adhesions upon adhesion and necessary for migration (Ishibe et al., 2004
; Klemke et al., 1998
), showed markedly reduced recruitment to the insoluble protein fraction (Fig. 3A).
|
to fibroblast biology, we assessed whether PKC
-deficient fibroblasts showed an impaired response to the potent pro-fibrotic, myofibroblast-inducing cytokine TGFβ (Leask and Abraham, 2004
-SMA stress fiber formation was impaired in the absence of PKC
(Fig. 4A). In addition, we used western blot analysis to show that the ability of TGFβ to induce phosphorylation of Smad3 was impaired in the absence of PKC
(Fig. 4B). As these data suggested TGFβ-induced gene expression responses might be impaired in the absence of PKC
we investigated whether loss of PKC
affected the ability of fibroblasts to induce the pro-fibrotic proteins CCN2, type I collagen, β1 integrin,
4 integrin and paxillin. We found that induction in response to TGFβ of all of these were impaired in PKC
-deficient fibroblasts (Fig. 4C). Finally, basal integrin,
-SMA and CCN2 expression were impaired (Fig. 4C). These results collectively imply that loss of PKC
significantly affects TGFβ signaling and myofibroblast induction in response to this growth factor.
|
knockout fibroblasts show reduced contraction and adhesion of ECM
+/+ and PKC
-/- fibroblasts to contract a collagen gel matrix, suspended in medium, over a 24 hour period (Grinnell, 2003
-/- fibroblasts exhibited reduced ability to contract a floating collagen gel matrix both in the presence and absence of added TGFβ1 (Fig. 4D). Consistent with this observation, the ability of normal fibroblasts to contract a collagen gel was reduced by a general protein kinase C inhibitor, calphostin (Fig. 4E). To extend these data, we conducted a contraction assay using a fibroblast-embedded collagen gel matrix, which is fixed at one end and attached to a force monitor (Eastwood et al., 1994
resulted in an impaired ability of fibroblasts to generate contractile force across a fixed collagen gel lattice containing fibroblasts (Fig. 5A). We then compared the abilities of PKC
+/+ and PKC
-/- fibroblasts to adhere to fibronectin, a key component of the provisional matrix deposited in the initial stages of wounding (Grinnell, 1984
-/- fibroblasts, relative to PKC
+/+ fibroblasts, displayed markedly reduced abilities to adhere to fibronectin and type I collagen (Fig. 5B). Collectively, these results are consistent with the wound healing phenotype of the PKC
-/- mice, and suggest PKC
is required for crucial features of wound closure, namely the ability of fibroblasts to adhere to and contract ECM.
|
|
knockout fibroblasts show reduced migratory ability that depends on Rac activation
+/+ and PKC
-/- fibroblasts to migrate on fibronectin by employing a so-called scratch wound assay in which a `wound' is introduced, by a pipette, in a confluent cell monolayer (Kinsella and Wight, 1986
-/- fibroblasts showed greatly reduced migratory ability compared with PKC
+/+ fibroblasts (Fig. 6). Collectively, these results are consistent with the notion that loss of PKC
results in impairment of the ability of fibroblasts to participate in wound healing responses. Our previous observation that FAK, but not Rac, was appropriately recruited to the cytoskeleton in PKC
-/- fibroblasts (Fig. 3) led us to investigate further the role of Rac in the phenotype of PKC
-/- fibroblasts. We then used a standard Rac activity assay to show that PKC
-/- fibroblasts, while displaying equal levels of Rac expression to wild-type cells with and without a 1-hour treatment with TGFβ, displayed markedly reduced Rac activity both in the presence and absence of added TGFβ (Fig. 7A,B).
|
Based on these results, we reasoned that Rac might not be effectively activated in PKC
-/- fibroblasts, and that the inability of FAK to be phosphorylated may be due to a markedly reduced level of Rac activity in PKC
-/- fibroblasts. We used western blot analysis to show that PKC
-/- fibroblasts cultured on fibronectin showed markedly endogenous reduced FAK phosphorylation (Fig. 8A). To assess whether the lower level of Rac contributed to the reduced FAK phosphorylation and to the reduced migration observed in PKC
-/- fibroblasts, we transfected an expression vector encoding constitutively activated Rac into PKC
-/- fibroblasts. Overexpression of constitutively activated Rac1 enhanced FAK phosphorylation and the reduced integrin β1 expression in PKC
-/- fibroblasts (Fig. 8A). Moreover, constitutively active Rac1 restored the ability of PKC
-/- fibroblasts to adhere to fibronectin and collagen, to possess abundant actin stress fibers (Fig. 8B,C) and to migrate (Fig. 8D). Thus, we concluded that PKC
was required for the activation of Rac, which was in turn required for maximal activation of FAK. It was still possible that the defect in PKC
-/- cells was due to the reduction of integrin expression (Fig. 4B) rather than to the inability of Rac to be activated. To investigate this possibility, we showed that Rac inhibition could reduce integrin β1 expression in PKC
+/+ cells, indicating that Rac activation is located upstream of integrin β1 expression (Fig. 9A). Moreover, Rac inhibition had a similar effect on wild-type fibroblasts to the loss of PKC
, namely Rac inhibition resulted in reduced
-SMA expression (Fig. 9A), ECM contraction (Fig. 9B) and cell migration (Fig. 9C). Collectively, our results are consistent with the notion that the markedly reduced ability of focal adhesions to be properly formed in PKC
-/- fibroblasts (owing to an inability to properly activate Rac and, as a result, to phosphorylate FAK) contributes to defective wound healing observed in PKC
-/- mice.
|
|
| Discussion |
|---|
|
|
|---|
is activated upon cell adhesion, the function of PKC
in focal adhesion formation and function is unknown. In this report, we test the effect of loss of PKC
in fibroblasts and show that recruitment of focal adhesion components to the cytoskeleton and phosphorylation of FAK was impaired in PKC
knockout fibroblasts. Consistent with this idea, PKC
-/- mice showed reduced rates of wound closure, cellularization and ECM deposition. In addition, isolated PKC
-/- fibroblasts showed reduced focal adhesion formation and migration and contraction of ECM. PKC
-/- fibroblasts showed reduced adhesive signaling, as visualized by FAK and Rac activation. As transfection of Rac at least partially restored the defects in FAK phosphorylation and migration in the PKC
-/- fibroblasts, suggesting that activation of Rac is downstream of PKC
but upstream of FAK. These results are consistent with recent findings that Rac is required for deformation-induced FAK phosphorylation (Chaturvedi et al., 2007
knockout fibroblasts, formation of the highly-contractile
-SMA cytoskeleton was markedly reduced in the absence of PKC
. Similar to this observation, PKC
-/- fibroblasts were able to form normal focal adhesions and actin fibers, but not the characteristic `supermature' focal adhesions, as visualized by intense vinculin staining, of myofibroblasts (Dugina et al., 2001
. Our results indicate that a crucial feature of this defect arises because of impaired myofibroblast formation. Although this defect is likely to have an indirect effect on the rate of re-epithelialization, we cannot exclude the possibility that loss of PKC
may also directly affect keratinocytes function. Evaluating this latter hypothesis is beyond the scope of our current study.
Fibrotic diseases are characterized by the failure to terminate normal tissue repair and the persistence of myofibroblasts within lesions (Gabbiani, 2003
; Shi-wen et al., 2004
; Chen et al., 2005
). Myofibroblast formation can be driven by many processes, including tension, TGFβ, thrombin, ET1 and CCN2 (Arora et al., 1999
; Hinz et al., 2001
; Shephard et al., 2004
; Shi-wen et al., 2004
; Shi-wen et al., 2006a
; Shi-wen et al., 2006b
; Chen et al., 2005
; Uehta et al., 1997; Leask and Abraham, 2004
; Leask and Abraham, 2006
; Goffin et al., 2006
; Kennedy et al., 2007
). These processes cooperate in inducing myofibroblast persistence within the milieu of tissue repair and fibrosis (Arora et al., 1999
; Hinz et al., 2001
; Shephard et al., 2004
; Shi-wen et al., 2006a
; Shi-wen et al., 2006b
). Thus, our results showing that PKC
mediates myofibroblast formation downstream are a useful first step in identifying a target suitable for anti-fibrotic drug intervention. Moreover, several growth factors and cytokines that promote myofibroblast formation are pleiotropic, which is reflected in the phenotype of their respective knockout mice being lethal or displaying severe developmental defects (e.g. Ivkovic et al., 2003
; Hines et al., 1994
; Kurihara et al., 1994
). Conversely, PKC
-/- mice are viable and healthy, unless subjected to particular stresses, such as subcutaneous injection of bacteria or hypoxia, in which case they show increased susceptibility to infection and reduced vasoconstriction, respectively (Castrillo et al., 2001
; Saurin et al., 2002
; Littler et al., 2003
). These data, combined with our observations that loss of PKC
results in impaired tissue repair and myofibroblast function, suggest that compared to the other pro-fibrotic targets described above, PKC
may be a suitable selective target for controlling tissue repair and in alleviating pathological scarring in vivo. Direct testing of this hypothesis using animal models of fibrosis is under way, but is beyond the scope of our current study. However, it is interesting to note that we have recently demonstrated that mice possessing a fibroblast-specific deletion of Rac1 are resistant to bleomycin-induced skin fibrosis (Liu et al., 2008
).
In conclusion, our results showing that PKC
is required for normal tissue repair and myofibroblast formation provide new insights into the function of specific PKC isoforms and into the integrated molecular mechanisms that underlie normal tissue repair.
| Materials and Methods |
|---|
|
|
|---|
+/+ and PKC
-/- mice aged 8 weeks, a kind gift from Peter Parker (University College London) (Castrillo et al., 2001
Cell culture, immunofluorescence and western analysis
Fibroblasts were isolated from explants (4- to 6-week-old animals) as previously described (Chen et al., 2004
). To mimic conditions in the provisional matrix post-wounding (Grinnell, 1994), cells were cultured on fibronectin (4 mg/ml Sigma) (Chen et al., 2004
). Cells were subjected to indirect immunofluorescence analysis as previously described (Chen et al., 2004
) using anti-
-SMA, rhodamine phalloidin (Sigma), anti-vinculin or anti-phospho-FAK (Cell Signaling), followed by an appropriate secondary antibody (Jackson ImmunoResearch). Photomicrographs were taken (Zeiss Axiphot) using a digital camera and Adobe Photoshop. Where indicated, cells were stained with DAPI (Molecular Probes, Eugene, OR) to detect nuclei. Alternatively, cells were lysed in 2% SDS, proteins quantified (Pierce) and subjected to western blot analysis as previously described (Shi-wen et al., 2004
; Shi-wen et al., 2006a
) with anti-β1 integrin, anti-
4 integrin (Santa Cruz), anti-CCN2 (Abcam), anti-paxillin (Cell Signaling), anti-type I collagen (Biodesign), anti-phosphoo-Smad3 (Rockland), anti-
-SMA or β-actin (Sigma) antibodies. Where indicated, cells were pretreated with the Rac inhibitor NSC23766 (100 µM, 1 hour, Calbiochem). Where indicated, cell extraction was performed in Triton lysis buffer (to generate a Triton-soluble fraction) and the Triton insoluble (cytoskeletal) fraction was solubilized in 2% SDS prior to western blot analysis. For the Rac rescue experiment, an expression vector encoding constitutively active Rac (V12rac1) under the control of the cytomegalovirus promoter (courtesy of Alan Hall, University College London) or an empty expression vector was transfected into cells using Fugene (Roche) at a ratio of 2 µg DNA:3 µl Fugene.
Tissue sectioning
Specimens were fixed after 24 hours in 10% neutral buffered formalin after which they were embedded in paraffin. Paraffin-embedded sections were cut (3 µm) on a Leica RM 2135 microtome. For
-SMA staining, an anti-
-SMA antibody (Chemicon: 1:50 dilution, 1 hour) was used followed by detection using Vectastain (Vector Labs), as described by the manufacturer. Samples were counterstained with Hematoxylin.
Rac activity assay
A standard commercially available Rac-GTP pulldown assay was used (Upstate Biotechnology; Lake Placid, NY). Rac activity assays were performed as described by the manufacturer. Briefly, cells were grown in 6 cm dishes. Cells were lysed in a buffer containing NP-40. A PAK-GSH fusion protein bound to agarose beads was added, and active Rac, which binds PAK-GSH, was separated by repetitive centrifugation and washing. After the specimens were boiled in Laemmli buffer, they were subjected to SDS-PAGE and Rac was quantified by Western blot analysis. In some experiments, cell lysates were stimulated with GTPS (100 µmol/l) to obtain maximal activation of Rac.
Adhesion assay
Fibroblasts were isolated and cultured as described above. Adhesion assays were performed essentially as previously described (Chen et al., 2004
). Wells of 96-well plates overnight, 4°C, with 10 µg/ml fibronectin (Sigma) or type I collagen (First Link) in 0.5% bovine serum albumin (BSA), 1 PBS. Wells were blocked for 1 hour in 10% BSA in PBS at room temperature. Fibroblasts were harvested with 2 mM EDTA in PBS (20 minutes, room temperature), washed twice with DMEM serum-free medium containing 1% BSA (Sigma, St Louis, MO), resuspended in the same medium at 2.5x105 cells/ml and 100 µl of suspension was incubated in each well for 1 hour. Non-adherent cells were subsequently removed by washing with PBS. To detect cell adhesion, an acid phosphatase assay was used, adherent cells were quantified by incubation with 100 µl substrate solution (0.1 M sodium acetate, pH 5.5; 10 mM -p-nitophenylphosphate and 0.1% Triton X-100) for 2 hours at 37°C. The reaction was stopped by the addition of 15 µl 1N NaOH/well and A450 was measured. Comparison of adhesive abilities was performed by using Student's unpaired t-test. P<0.05 was considered to be statistically significant.
Collagen gel contraction
Experiments were performed essentially as described previously (Shi-wen et al., 2004
). Briefly, 24-well tissue culture plates were pre-coated with BSA. Cells were used at passage 3. Trypsinized fibroblasts were suspended in MCDB medium (Sigma) and mixed with collagen solution [one part of 0.2 M N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid (HEPES), pH 8.0; four parts collagen (Vitrogen-100, 3 mg/ml) and five parts of MCDB X 2] yielding a final concentration of 80,000 cells per ml and 1.2 mg/ml collagen. Collagen/cell suspension (1 ml) was added to each well. After polymerization, gels were detached from wells by adding 1 ml of MCDB medium. Contraction of the gel was quantified by loss of gel weight and decrease in gel diameter over a 24-hour period
Fibroblast populated collagen lattices (FPCL)
Measurement of contractile force generated within a three-dimensional, tethered FPCL was performed as described previously (Eastwood et al., 1994
; Shi-wen et al., 2004
) Using 1106 cells/ml of collagen gel (First Link, UK), we measured the force generated across the collagen lattice with a culture force monitor, which measures forces exerted by cells within a collagen lattice over 24 hours as fibroblasts attach, spread, migrate and differentiate into myofibroblasts. In brief, a rectangular fibroblast seeded collagen gel was cast and floated in medium in 2% FCS in the presence or absence of TGFβ1 (4 ng/ml), while tethered to two flotation bars on either side of the long edges, in turn attached to a ground point at one end and a force transducer at the other. Cell-generated tensional forces in the collagen gel are detected by the force transducer and logged into a personal computer. Graphical readings are produced every 15 seconds providing a continuous output of force (Dynes: 110-5N) generated (Eastwood et al., 2004). The cells used in these experiments were passage matched; experiments were run in parallel and three independent times. A representative trace is shown.
Migration assays
For in vitro wounding (migration) experiments, cultured fibroblasts obtained from wild-type or PKC
KO mice were grown on fibronectin in 12-well plates. Medium was removed and cells were once rinsed with serum-free medium + 0.1% BSA and were cultured for 24 hours in serum-free medium + 0.1% BSA. The monolayer was artificially injured by scratching across the plate with a blue pipette tip (
1.3 mm width) (Kinsella and Wight, 1986
). The wells were washed twice to remove detached cells or cell debris. The cells were then cultured in serum-free medium with or without added TGFβ1 (4 ng/ml R&D Systems). Mitomycin C (10 µg/ml) was always included in the media to prevent cell proliferation. After 48 hours, five representative images of the scratched areas under each condition were photographed.
| Acknowledgments |
|---|
knockout mice and advice in their use, and Alan Hall (University College London, London, UK) for the expression vector encoding constitutively active Rac1. | Footnotes |
|---|
| References |
|---|
|
|
|---|
Arora, P. D., Narani, N. and McCulloch, C. A. (1999). The compliance of collagen gels regulates transforming growth factor-beta induction of alpha-smooth muscle actin in fibroblasts. Am. J. Pathol. 154, 871-882.
Besson, A., Wilson, T. L. and Yong, V. W. (2002). The anchoring protein RACK1 links protein kinase Cepsilon to integrin beta chains. Requirements for adhesion and motility. J. Biol. Chem. 277, 22073-22084.
Bogatkevich, G. S., Tourkina, E., Abrams, C. S., Harley, R. A., Silver, R. M. and Ludwicka-Bradley, A. (2003). Contractile activity and smooth muscle alpha-actin organization in thrombin-induced human lung myofibroblasts. Am. J. Physiol. Lung Cell Mol. Physiol. 285, L334-L343.
Burridge, K. and Chrzanowska-Wodnicka, M. (1996). Focal adhesions, contractility, and signaling. Annu. Rev. Cell Dev. Biol. 12, 463-518.[CrossRef][Medline]
Carter, C. A. and Kane, C. J. (2004). Therapeutic potential of natural compounds that regulate the activity of protein kinase C. Curr. Med. Chem. 11, 2883-2902.[Medline]
Castrillo, A., Pennington, D. J., Otto, F., Parker, P. J., Owen, M. J. and Bosca, L. (2001). Protein kinase Cepsilon is required for macrophage activation and defense against bacterial infection. J. Exp. Med. 194, 1231-1242.
Chaturvedi, L. S., Marsh, H. M., Shang, X., Zheng, Y. and Basson, M. D. (2007). Repetitive deformation activates focal adhesion kinase and ERK mitogenic signals in human Caco-2 intestinal epithelial cells through Src and Rac1. J. Biol. Chem. 282, 14-28.
Chen, Y., Abraham, D. J., Shi-wen, X., Pearson, J. D., Black, C. M., Lyons, K. M. and Leask, A. (2004). CCN2 (connective tissue growth factor) promotes fibroblast adhesion to fibronectin. Mol. Biol. Cell 15, 5635-5646.
Chen, Y., Shi-Wen, X., van Beek, J., Kennedy, L., McLeod, M., Renzoni, E. A., Bou-Gharios, G., Wilcox-Adelman, S., Goetinck, P. F., Eastwood, M. et al. (2005). Matrix contraction by dermal fibroblasts requires transforming growth factor-beta/activin-linked kinase 5, heparan sulfate-containing proteoglycans, and MEK/ERK: insights into pathological scarring in chronic fibrotic disease. Am. J. Pathol. 167, 1699-1711.
Dugina, V., Fontao, L., Chaponnier, C., Vasiliev, J. and Gabbiani, G. (2001). Focal adhesion features during myofibroblastic differentiation are controlled by intracellular and extracellular factors. J. Cell Sci. 114, 3285-3296.[Medline]
Eastwood, M., McGrouther, D. A. and Brown, R. A. (1994). Fibroblast responses to mechanical forces. Biochim. Biophys. Acta 1201, 186-192.[Medline]
Eckes, B., Kessler, D., Aumailley, M. and Krieg, T. (1999). Interactions of fibroblasts with the extracellular matrix: implications for the understanding of fibrosis. Springer Semin. Immunopathol. 21, 415-429.[Medline]
Gabbiani, G. (2003). The myofibroblast in wound healing and fibrocontractive diseases. J. Pathol. 200, 500-503.[CrossRef][Medline]
Goffin, J. M., Pittet, P., Csucs, G., Lussi, J. W., Meister, J. J. and Hinz, B. (2006). Focal adhesion size controls tension-dependent recruitment of alpha-smooth muscle actin to stress fibers. J. Cell Biol. 172, 259-268.
Grinnell, F. (1984). Fibronectin and wound healing. J. Cell Biochem. 26, 107-116.[CrossRef][Medline]
Grinnell, F. (2003). Fibroblast biology in three-dimensional collagen matrices. Trends Cell Biol. 13, 264-269.[CrossRef][Medline]
Hagel, M., George, E. L., Kim, A., Tamimi, R., Opitz, S. L., Turner, C. E., Imamoto, A. and Thomas, S. M. (2002). The adaptor protein paxillin is essential for normal development in the mouse and is a critical transducer of fibronectin signaling. Mol. Cell. Biol. 22, 901-915.
Hines, K. L., Kulkarni, A. B., McCarthy, J. B., Tian, H., Ward, J. M., Christ, M., McCartney-Francis, N. L., Furcht, L. T., Karlsson, S. and Wahl, S. M. (1994). Synthetic fibronectin peptides interrupt inflammatory cell infiltration in transforming growth factor beta 1 knockout mice. Proc. Natl. Acad. Sci. USA 91, 5187-5191.
Hinz, B. and Gabbiani, G. (2003). Mechanisms of force generation and transmission by myofibroblasts. Curr. Opin. Biotechnol. 14, 538-546.[CrossRef][Medline]
Hinz, B., Mastrangelo, D., Iselin, C. E., Chaponnier, C. and Gabbiani, G. (2001). Mechanical tension controls granulation tissue contractile activity and myofibroblast differentiation. Am. J. Pathol. 159, 1009-1020.
Ilic, D., Furuta, Y., Kanazawa, S., Takeda, N., Sobue, K., Nakatsuji, N., Nomura, S., Fujimoto, J., Okada, M., Yamamoto, T. et al. (1995). Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 377, 539-544.[CrossRef][Medline]
Ishibe, S., Joly, D., Liu, Z. X. and Cantley, L. G. (2004). Paxillin serves as an ERK-regulated scaffold for coordinating FAK and Rac activation in epithelial morphogenesis. Mol. Cell 6, 257-267.
Ivaska, J., Whelan, R. D., Watson, R. and Parker, P. J. (2002). PKC epsilon controls the traffic of beta1 integrins in motile cells. EMBO J. 21, 3608-3619.[CrossRef][Medline]
Ivaska, J., Bosca, L. and Parker, P. J. (2003). PKCepsilon is a permissive link in integrin-dependent IFN-gamma signalling that facilitates JAK phosphorylation of STAT1. Nat. Cell Biol. 5, 363-369.[CrossRef][Medline]
Ivkovic, S., Yoon, B. S., Popoff, S. N., Safadi, F. F., Libuda, D. E., Stephenson, R. C., Daluiski, A. and Lyons, K. M. (2003). Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development 130, 2779-2791.
Kennedy, L., Liu, S., Shi-Wen, X., Chen, Y., Eastwood, M., Carter, D. E., Lyons, K. M., Black, C. M., Abraham, D. J. and Leask, A. (2007). CCN2 is necessary for the function of mouse embryonic fibroblasts. Exp. Cell Res. 313, 952-964.[CrossRef][Medline]
Kinsella, M. G. and Wight, T. N. (1986). Modulation of sulfated proteoglycan synthesis by bovine aortic endothelial cells during migration. J. Cell Biol. 102, 679-687.
Klemke, R. L., Leng, J., Molander, R., Brooks, P. C., Vuori, K., Cheresh, D. A. (1998). CAS/Crk coupling serves as a "molecular switch" for induction of cell migration. J. Cell Biol. 140, 961-972.
Kurihara, Y., Kurihara, H., Suzuki, H., Kodama, T., Maemura, K., Nagai, R., Oda, H., Kuwaki, T., Cao, W. H., Kamada, N. et al. (1994). Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 368, 703-710.[CrossRef][Medline]
Leask, A. and Abraham, D. J. (2004). TGF-beta signaling and the fibrotic response. FASEB J. 18, 816-827.
Leask, A. and Abraham, D. J. (2006). All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J. Cell Sci. 119, 4803-4810.
Littler, C. M., Morris, K. G., Jr, Fagan, K. A., McMurtry, I. F., Messing, R. O. and Dempsey, E. C. (2003). Protein kinase C-epsilon-null mice have decreased hypoxic pulmonary vasoconstriction. Am. J. Physiol. Heart Circ. Physiol. 284, H1321-H1331.
Liu, S., Kapoor, M., Shi-wen, X., Kennedy, L., Chen. Y., Eastwood, M., Denton, C. P., Glogauer, M., Abraham, D. J., Leask, A. et al. (2008). Investigation of the role of Rac1 in a bleomycin-induced scleroderma model using fibroblast-specific Rac1 knockout mice. Arthritis Rheum. 58, 2189-2195.[CrossRef][Medline]
Martin, P. (1997). Wound healing-aiming for perfect skin regeneration. Science 276, 75-81.
Midwood, K. S. and Schwarzbauer, J. E. (2002). Tenascin-C modulates matrix contraction via focal adhesion kinase- and Rho-mediated signaling pathways. Mol. Biol. Cell 13, 3601-3613.
Moscat, J., Rennert, P. and Diaz-Meco, M. T. (2006). PKCzeta at the crossroad of NF-kappaB and Jak1/Stat6 signaling pathways. Cell Death Differ. 13, 702-711.[CrossRef][Medline]
Prekeris, R., Hernandez, R. M., Mayhew, M. W., White, M. K. and Terrian, D. M. (1998). Molecular analysis of the interactions between protein kinase C-epsilon and filamentous actin. J. Biol. Chem. 273, 26790-26798.
Saurin, A. T., Pennington, D. J., Raat, N. J., Latchman, D. S., Owen, M. J. and Marber, M. S. (2002). Targeted disruption of the protein kinase C epsilon gene abolishes the infarct size reduction that follows ischaemic preconditioning of isolated buffer-perfused mouse hearts. Cardiovasc. Res. 55, 672-680.
Shephard, P., Hinz, B., Smola-Hess, S., Meister, J. J., Krieg, T. and Smola, H. (2004). Dissecting the roles of endothelin, TGF-beta and GM-CSF on myofibroblast differentiation by keratinocytes. Thromb. Haemost. 92, 262-274.[Medline]
Shi-wen, X., Chen, Y., Denton, C. P., Eastwood, M., Renzoni, E. A., Bou-Gharios, G., Pearson, J. D., Dashwood, M., du Bois, R. M., Black, C. M. et al. (2004). Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts. Mol. Biol. Cell 15, 2707-2719.
Shi-wen, X., Stanton, L. A., Kennedy, L., Pala, D., Chen, Y., Howat, S. L., Renzoni, E. A., Carter, D. E., Bou-Gharios, G., Stratton, R. J. et al. (2006a). CCN2 is necessary for adhesive responses to transforming growth factor-beta1 in embryonic fibroblasts. J. Biol. Chem. 281, 10715-10726.
Shi-wen, X., Rodriguez-Pascual, F., Lamas, S., Holmes, A., Howat, S., Pearson, J. D., Dashwood, M. R., du Bois, R. M., Denton, C. P., Black, C. M. et al. (2006b). Constitutive ALK5-independent c-Jun N-terminal kinase activation contributes to endothelin-1 overexpression in pulmonary fibrosis: evidence of an autocrine endothelin loop operating through the endothelin A and B receptors. Mol. Cell. Biol. 26, 5518-5527.
Tscharntke, M., Pofahl, R., Chrostek-Grashoff, A., Smyth, N., Niessen, C., Niemann, C., Hartwig, B., Herzog, V., Klein, H. W., Krieg, T. et al. (2007). Impaired epidermal wound healing in vivo upon inhibition or deletion of Rac1. J. Cell. Sci. 120, 1480-1490.
Teicher, B. A. (2006). Protein kinase C as a therapeutic target. Clin. Cancer Res. 12, 5336-5345.
Turner, C. E. (2000). Paxillin and focal adhesion signalling. Nat. Cell Biol. 2, E231-E236.[CrossRef][Medline]
Uehata, M., Ishizaki, T., Satoh, H., Ono, T., Kawahara, T., Morishita, T., Tamakawa, H., Yamagami, K., Inui, J., Maekawa, M. et al. (1997). Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389, 990-994.[CrossRef][Medline]
Way, K. J., Chou, E. and King, G. L. (2000). Identification of PKC-isoform-specific biological actions using pharmacological approaches. Trends Pharmacol. Sci. 21, 181-187.[CrossRef][Medline]
Webb, D. J., Donais, K., Whitmore, L. A., Thomas, S. M., Turner, C. E., Parsons, J. T. and Horwitz, A. F. (2004). FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat. Cell Biol. 6, 154-161.[CrossRef][Medline]
Woods, A. and Couchman, J. R. (1992). Protein kinase C involvement in focal adhesion formation. J. Cell Sci. 101, 277-290.
Zamir, E. and Geiger, B. (2001). Molecular complexity and dynamics of cell-matrix adhesions. J. Cell Sci. 114, 3583-3590.[Medline]
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
J. M. Carvajal-Gonzalez, A. C. Roman, M. I. Cerezo-Guisado, E. M. Rico-Leo, G. Martin-Partido, and P. M. Fernandez-Salguero Loss of dioxin-receptor expression accelerates wound healing in vivo by a mechanism involving TGF{beta} J. Cell Sci., June 1, 2009; 122(11): 1823 - 1833. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||